AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population
Recruiting
Observational Study
Coronary Artery Disease (CAD)
Artificial Intelligence Algorithms
Face
Screening
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,392 (estimated)
- Sponsor
- China National Center for Cardiovascular Diseases · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the effectiveness of this facial image-based AI algorithm for screening CAD in high-risk community populations (specifically individuals with diabetes, hypertension, or aged over 65). The main objectives are:
1. To verify if the AI algorithm can accurately distinguish between high-risk and low-risk groups by comparing the actual prevalence of CAD in these groups.
2. To…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \>= 18 years.
* Community high-risk population, defined as individuals meeting at least one of the following criteria:
1. Diagnosed with Diabetes Mellitus;
2. Diagnosed with Hypertension;
3. Advanced age (\> 65 years old).
Exclusion Criteria:
* Prior confirmed dia…
Contacts